Shares of PACS Group, Inc. (NYSE:PACS – Get Free Report) have received an average rating of “Moderate Buy” from the five research firms that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $43.25.
A number of brokerages have issued reports on PACS. Royal Bank Of Canada reissued an “outperform” rating and issued a $47.00 price target on shares of PACS Group in a report on Friday, December 19th. JPMorgan Chase & Co. started coverage on shares of PACS Group in a research report on Wednesday, December 17th. They set an “overweight” rating and a $44.00 price objective on the stock. Wall Street Zen lowered shares of PACS Group from a “buy” rating to a “hold” rating in a research note on Saturday. UBS Group restated a “buy” rating and issued a $42.00 price target (down previously from $50.00) on shares of PACS Group in a research note on Thursday, December 18th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of PACS Group in a research report on Monday, December 22nd.
View Our Latest Research Report on PACS
Insider Buying and Selling
Institutional Trading of PACS Group
Several hedge funds have recently bought and sold shares of PACS. Cubist Systematic Strategies LLC bought a new position in shares of PACS Group in the first quarter worth about $198,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of PACS Group by 6.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,280 shares of the company’s stock worth $262,000 after purchasing an additional 1,443 shares during the period. Millennium Management LLC raised its position in shares of PACS Group by 68.3% during the 1st quarter. Millennium Management LLC now owns 859,295 shares of the company’s stock valued at $9,658,000 after purchasing an additional 348,743 shares during the period. Jones Financial Companies Lllp purchased a new position in shares of PACS Group during the 1st quarter valued at $64,000. Finally, Caxton Associates LLP purchased a new stake in PACS Group in the 1st quarter worth $163,000.
PACS Group Trading Down 1.4%
Shares of PACS opened at $38.13 on Thursday. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.94 and a quick ratio of 0.94. PACS Group has a 1-year low of $7.50 and a 1-year high of $43.08. The company has a market capitalization of $5.97 billion, a P/E ratio of 36.31, a P/E/G ratio of 1.29 and a beta of -0.64. The firm’s 50 day simple moving average is $36.42 and its 200 day simple moving average is $21.69.
PACS Group (NYSE:PACS – Get Free Report) last posted its quarterly earnings data on Wednesday, November 19th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.36). PACS Group had a return on equity of 21.39% and a net margin of 3.29%.The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.11 billion. Sell-side analysts forecast that PACS Group will post 1.01 earnings per share for the current fiscal year.
PACS Group Company Profile
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
See Also
- Five stocks we like better than PACS Group
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
